Overview

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions

Status:
COMPLETED
Trial end date:
2025-03-12
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of BR1015 and co-administration of BR1015-3 and BR1015-2 in healthy volunteers under fasting conditions
Phase:
PHASE1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd